MedTrace Logo

Initial Experience With a Novel Single-Balloon Enteroscopy System in Children With IBD

NCT02629211 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2016-08-23

No results posted yet for this study

Summary

To evaluate the safety and efficacy of the NaviAid™ AB in children with known or suspected IBD.

Conditions

  • Inflammatory Bowel Diseases
  • Colitis, Ulcerative
  • Crohn Disease

Interventions

DEVICE

NaviAid™ AB

NaviAid™ AB Procedure

Sponsors & Collaborators

  • Smart Medical Systems Ltd.

    lead INDUSTRY

Principal Investigators

  • Efrat Broide · Assaf-Harofeh Medical Center

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
8 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2017-01-31
Completion
2017-02-28

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02629211 on ClinicalTrials.gov